Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial
Takeshi Kimura(Kyoto University), Nobuhiro Suematsu(Saiseikai Fukuoka General Hospital), Yuji Ikari(Tokai University), Yoshihiro Morino(Iwate Medical University), Keiichi Igarashi Hanaoka, Kazuya Kawai(Chikamori Hospital), Takafumi Yokomatsu(Mitsubishi Kyoto Hospital), Masanobu Ohya(Kurashiki Central Hospital), Kensuke Takagi(Ogaki Municipal Hospital), Masayuki Doi(Kagawa Prefectural Central Hospital), Kiyoshi Hibi(Yokohama City University Medical Center), Hiroki Sakamoto(Shizuoka General Hospital), Mitsuru Abe(Kyoto Medical Center), Mamoru Nanasato(Japanese Red Cross Nagoya Daini Hospital), Hideki Okayama(Ehime Prefectural Central Hospital), Itaru Takamisawa(Sakakibara Hospital), Yutaka Furukawa(Kobe City Medical Center General Hospital), Kenji Andò(Kokura Memorial Hospital), Hiroki Shiomi(Kyoto University), Hirotoshi Watanabe(Kyoto University), Toshiyuki Noda(Gifu Prefectural General Medical Center), Satoru Suwa(Juntendo University Shizuoka Hospital), Kazushige Kadota(Kurashiki Central Hospital), Yoshihisa Nakagawa(Tenri Hospital), Takeshi Morimoto(Hyogo Medical University), Kōichi Nakao(Saiseikai Kumamoto Hospital), Ken Kozuma(Teikyo University Hospital), Yoshitane Seino(Star General Hospital), Masahiro Natsuaki(Saga University), Masahiro Yagi(Sendai Medical Center), Kengo Tanabe, Yoshiki Hata, Toshiaki Toyota(Kobe City Medical Center General Hospital), Takenori Domei(Kokura Memorial Hospital), Tomohisa Tada(Shizuoka General Hospital)
Cited by 62
Related Papers
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345